EMPLI Stock Overview
Emplicure AB (publ) engages in the research and development of pharmaceutical products primarily for the treatment of chronic pain in Sweden.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Emplicure AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 0.47 |
52 Week High | SEK 1.53 |
52 Week Low | SEK 0.34 |
Beta | 1.32 |
11 Month Change | 13.25% |
3 Month Change | 28.42% |
1 Year Change | -68.46% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -86.17% |
Recent News & Updates
Recent updates
Shareholder Returns
EMPLI | SE Pharmaceuticals | SE Market | |
---|---|---|---|
7D | 9.3% | -3.2% | -7.2% |
1Y | -68.5% | 70.7% | 10.7% |
Return vs Industry: EMPLI underperformed the Swedish Pharmaceuticals industry which returned 28.5% over the past year.
Return vs Market: EMPLI underperformed the Swedish Market which returned 5.8% over the past year.
Price Volatility
EMPLI volatility | |
---|---|
EMPLI Average Weekly Movement | 13.3% |
Pharmaceuticals Industry Average Movement | 10.9% |
Market Average Movement | 5.9% |
10% most volatile stocks in SE Market | 12.2% |
10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: EMPLI has not had significant price volatility in the past 3 months.
Volatility Over Time: EMPLI's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | Hakan Engqvist | emplicure.com |
Emplicure AB (publ) engages in the research and development of pharmaceutical products primarily for the treatment of chronic pain in Sweden. It provides Empli03, an oral buccal tablet; and Amp01, an oral nicotine pouche. The company was incorporated in 2014 and is based in Uppsala, Sweden.
Emplicure AB (publ) Fundamentals Summary
EMPLI fundamental statistics | |
---|---|
Market cap | SEK 46.47m |
Earnings (TTM) | -SEK 27.31m |
Revenue (TTM) | n/a |
-339.2x
P/S Ratio-1.7x
P/E RatioIs EMPLI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EMPLI income statement (TTM) | |
---|---|
Revenue | -SEK 137.00k |
Cost of Revenue | SEK 769.00k |
Gross Profit | -SEK 906.00k |
Other Expenses | SEK 26.41m |
Earnings | -SEK 27.31m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.28 |
Gross Margin | 661.31% |
Net Profit Margin | 19,935.04% |
Debt/Equity Ratio | 0% |
How did EMPLI perform over the long term?
See historical performance and comparison